Methods A PI3K inhibitor qualitative study employing the
phenomenological approach was used. In-depth semi-structured interviews with a purposive convenience sample of 20 participants were conducted. Twenty participants were recruited from community pharmacies offering continuous positive airways pressure (CPAP) device provision and a teaching hospital in Sydney, Australia. Interviews were digitally recorded and transcribed verbatim, coded using Nvivo8 software and analysed based on the ‘framework’ method. Key findings The quality and delivery of information at diagnosis was reported to have been inappropriate for participants’ personal needs. Many barriers emerged in regards to CPAP use, consistent with current literature. Participants’ self-reported individual styles, coping practices and health beliefs appeared to be the most influential factors in CPAP uptake and adherence, regardless of mechanical advancements and environmental support. High satisfaction was expressed with CPAP obtainment from pharmacy services listing convenience and good service as notable characteristics. Conclusions Community pharmacies have the potential to increase OSA awareness and improve optimal usage of CPAP. Psychosocial based models
of adherence intervention Ruxolitinib could potentially be implemented through CPAP providers, including the community pharmacy, to address some of these factors which impede CPAP adherence. “
“Objectives There are conflicting results in studies of pharmacists undertaking medication reviews for older people. With increasing promotion and funding for ‘medication reviews’ there is a need for them to be standardised, and to determine
their effectiveness and the feasibility of providing them from a community pharmacy. The objective Staurosporine was to determine whether involvement of community pharmacists undertaking clinical medication reviews, working with general practitioners, improved medicine-related therapeutic outcomes for patients. Methods A randomised controlled trial was carried out in people 65 years and older on five or more prescribed medicines. Community pharmacists undertook a clinical medication review (Comprehensive Pharmaceutical Care) and met with the patient’s general practitioner to discuss recommendations about possible medicine changes. The patients were followed-up 3-monthly. The control group received usual care. The main outcome measures were Quality of Life (SF-36) and Medication Appropriateness Index. Key findings A total of 498 patients were enrolled in the study. The quality-of-life domains of emotional role and social functioning were significantly reduced in the intervention group compared to the control group.